Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Aug;67(2):174–179. doi: 10.1136/jnnp.67.2.174

Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy

F Mastaglia 1, K Nowak 1, R Stell 1, B Phillips 1, J Edmondston 1, S Dorosz 1, S Wilton 1, J Hallmayer 1, B Kakulas 1, N Laing 1
PMCID: PMC1736462  PMID: 10406984

Abstract

OBJECTIVES—To determine the molecular basis for autosomal dominant intermediate hereditary motor and sensory neuropathy (HMSN) in a four generation family. The gene defects in families with intermediate HMSN are not known, but it has been suggested that most have X linked HMSN.
METHODS—All participating family members were examined clinically. Genomic DNA was obtained from 10 affected and seven unaffected members. Linkage analysis for the known HMSN loci was first performed. Mutations in the peripheral myelin protein zero gene (PMP0) were sought in two affected members, using one unaffected member for comparison, by amplification of the six exons of the gene followed by single strand conformation polymorphism (SSCP) analysis, dideoxy fingerprinting (ddF), and sequencing. Subsequently, the mutation was screened for in all affected and unaffected members in the family using Alu I digestion and in 100 unrelated control subjects using "snap back" SSCP analysis. Sequencing of cDNA from a sural nerve biopsy from an affected member was also performed.
RESULTS—The clinical phenotype was of variable severity, with motor nerve conduction velocities in the intermediate range. Linkage to PMP0 was demonstrated. Analysis of genomic DNA and cDNA for PMP0 identified a novel codon 35 GAC to TAC mutation. The mutation produces an inferred amino acid change of aspartate to tyrosine at codon six of the processed protein (Asp6Tyr) in the extracellular domain and was present in all affected family members but not in 100 unrelated controls.
CONCLUSIONS—The present findings further extend the range of phenotypes associated with PMP0 mutations and indicate that families with "intermediate" HMSN need not necessarily be X-linked as previously suggested.



Full Text

The Full Text of this article is available as a PDF (202.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beggs A. H., Phillips H. A., Kozman H., Mulley J. C., Wilton S. D., Kunkel L. M., Laing N. G. A (CA)n repeat polymorphism for the human skeletal muscle alpha-actinin gene ACTN2 and its localization on the linkage map of chromosome 1. Genomics. 1992 Aug;13(4):1314–1315. doi: 10.1016/0888-7543(92)90054-v. [DOI] [PubMed] [Google Scholar]
  2. Ben Othmane K., Middleton L. T., Loprest L. J., Wilkinson K. M., Lennon F., Rozear M. P., Stajich J. M., Gaskell P. C., Roses A. D., Pericak-Vance M. A. Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics. 1993 Aug;17(2):370–375. doi: 10.1006/geno.1993.1334. [DOI] [PubMed] [Google Scholar]
  3. Bergoffen J., Scherer S. S., Wang S., Scott M. O., Bone L. J., Paul D. L., Chen K., Lensch M. W., Chance P. F., Fischbeck K. H. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 1993 Dec 24;262(5142):2039–2042. doi: 10.1126/science.8266101. [DOI] [PubMed] [Google Scholar]
  4. Brust J. C., Lovelace R. E., Devi S. Clinical and electrodiagnostic features of Charcot-Marie-Tooth syndrome. Acta Neurol Scand Suppl. 1978;68:1–142. [PubMed] [Google Scholar]
  5. Buchthal F., Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain. 1977 Mar;100(Pt 1):41–66. doi: 10.1093/brain/100.1.41. [DOI] [PubMed] [Google Scholar]
  6. Cottingham R. W., Jr, Idury R. M., Schäffer A. A. Faster sequential genetic linkage computations. Am J Hum Genet. 1993 Jul;53(1):252–263. [PMC free article] [PubMed] [Google Scholar]
  7. Davis C. J., Bradley W. G., Madrid R. The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum. 1978 Dec;26(4):311–349. [PubMed] [Google Scholar]
  8. Dyck P. J., Lambert E. H. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol. 1968 Jun;18(6):603–618. doi: 10.1001/archneur.1968.00470360025002. [DOI] [PubMed] [Google Scholar]
  9. Fairweather N., Bell C., Cochrane S., Chelly J., Wang S., Mostacciuolo M. L., Monaco A. P., Haites N. E. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1) Hum Mol Genet. 1994 Jan;3(1):29–34. doi: 10.1093/hmg/3.1.29. [DOI] [PubMed] [Google Scholar]
  10. Gabreëls-Festen A. A., Hoogendijk J. E., Meijerink P. H., Gabreëls F. J., Bolhuis P. A., van Beersum S., Kulkens T., Nelis E., Jennekens F. G., de Visser M. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology. 1996 Sep;47(3):761–765. doi: 10.1212/wnl.47.3.761. [DOI] [PubMed] [Google Scholar]
  11. Giese K. P., Martini R., Lemke G., Soriano P., Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell. 1992 Nov 13;71(4):565–576. doi: 10.1016/0092-8674(92)90591-y. [DOI] [PubMed] [Google Scholar]
  12. Hahn A. F., Brown W. F., Koopman W. J., Feasby T. E. X-linked dominant hereditary motor and sensory neuropathy. Brain. 1990 Oct;113(Pt 5):1511–1525. doi: 10.1093/brain/113.5.1511. [DOI] [PubMed] [Google Scholar]
  13. Harding A. E. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain. 1995 Jun;118(Pt 3):809–818. doi: 10.1093/brain/118.3.809. [DOI] [PubMed] [Google Scholar]
  14. Harding A. E., Thomas P. K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain. 1980 Jun;103(2):259–280. doi: 10.1093/brain/103.2.259. [DOI] [PubMed] [Google Scholar]
  15. Hayasaka K., Himoro M., Sato W., Takada G., Uyemura K., Shimizu N., Bird T. D., Conneally P. M., Chance P. F. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet. 1993 Sep;5(1):31–34. doi: 10.1038/ng0993-31. [DOI] [PubMed] [Google Scholar]
  16. Hayasaka K., Himoro M., Sawaishi Y., Nanao K., Takahashi T., Takada G., Nicholson G. A., Ouvrier R. A., Tachi N. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet. 1993 Nov;5(3):266–268. doi: 10.1038/ng1193-266. [DOI] [PubMed] [Google Scholar]
  17. Ionasescu V., Searby C., Sheffield V. C., Roklina T., Nishimura D., Ionasescu R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet. 1996 Sep;5(9):1373–1375. doi: 10.1093/hmg/5.9.1373. [DOI] [PubMed] [Google Scholar]
  18. Kirschner D. A., Szumowski K., Gabreëls-Festen A. A., Hoogendijk J. E., Bolhuis P. A. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects. J Neurosci Res. 1996 Nov 15;46(4):502–508. doi: 10.1002/(SICI)1097-4547(19961115)46:4<502::AID-JNR12>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  19. Knezevic W., Mastaglia F. L. Neuropathy associated with Brescia-Cimino arteriovenous fistulas. Arch Neurol. 1984 Nov;41(11):1184–1186. doi: 10.1001/archneur.1984.04050220082022. [DOI] [PubMed] [Google Scholar]
  20. Krawczak M., Cooper D. N. The human gene mutation database. Trends Genet. 1997 Mar;13(3):121–122. doi: 10.1016/s0168-9525(97)01068-8. [DOI] [PubMed] [Google Scholar]
  21. Kulkens T., Bolhuis P. A., Wolterman R. A., Kemp S., te Nijenhuis S., Valentijn L. J., Hensels G. W., Jennekens F. G., de Visser M., Hoogendijk J. E. Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet. 1993 Sep;5(1):35–39. doi: 10.1038/ng0993-35. [DOI] [PubMed] [Google Scholar]
  22. Kwon J. M., Elliott J. L., Yee W. C., Ivanovich J., Scavarda N. J., Moolsintong P. J., Goodfellow P. J. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet. 1995 Oct;57(4):853–858. [PMC free article] [PubMed] [Google Scholar]
  23. Lathrop G. M., Lalouel J. M. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet. 1984 Mar;36(2):460–465. [PMC free article] [PubMed] [Google Scholar]
  24. Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. J., Saucedo-Cardenas O., Barker D. F., Killian J. M., Garcia C. A. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991 Jul 26;66(2):219–232. doi: 10.1016/0092-8674(91)90613-4. [DOI] [PubMed] [Google Scholar]
  25. Marrosu M. G., Vaccargiu S., Marrosu G., Vannelli A., Cianchetti C., Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology. 1998 May;50(5):1397–1401. doi: 10.1212/wnl.50.5.1397. [DOI] [PubMed] [Google Scholar]
  26. Meijerink P. H., Hoogendijk J. E., Gabreëls-Festen A. A., Zorn I., Veldman H., Baas F., de Visser M., Bolhuis P. A. Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies. Ann Neurol. 1996 Oct;40(4):672–675. doi: 10.1002/ana.410400418. [DOI] [PubMed] [Google Scholar]
  27. Nelis E., Timmerman V., De Jonghe P., Vandenberghe A., Pham-Dinh D., Dautigny A., Martin J. J., Van Broeckhoven C. Rapid screening of myelin genes in CMT1 patients by SSCP analysis: identification of new mutations and polymorphisms in the P0 gene. Hum Genet. 1994 Dec;94(6):653–657. doi: 10.1007/BF00206959. [DOI] [PubMed] [Google Scholar]
  28. Nicholson G., Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology. 1993 Dec;43(12):2558–2564. doi: 10.1212/wnl.43.12.2558. [DOI] [PubMed] [Google Scholar]
  29. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766–2770. doi: 10.1073/pnas.86.8.2766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  31. Patel P. I., Lupski J. R. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet. 1994 Apr;10(4):128–133. doi: 10.1016/0168-9525(94)90214-3. [DOI] [PubMed] [Google Scholar]
  32. Patel P. I., Roa B. B., Welcher A. A., Schoener-Scott R., Trask B. J., Pentao L., Snipes G. J., Garcia C. A., Francke U., Shooter E. M. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992 Jun;1(3):159–165. doi: 10.1038/ng0692-159. [DOI] [PubMed] [Google Scholar]
  33. Pham-Dinh D., Fourbil Y., Blanquet F., Mattéi M. G., Roeckel N., Latour P., Chazot G., Vandenberghe A., Dautigny A. The major peripheral myelin protein zero gene: structure and localization in the cluster of Fc gamma receptor genes on human chromosome 1q21.3-q23. Hum Mol Genet. 1993 Dec;2(12):2051–2054. doi: 10.1093/hmg/2.12.2051. [DOI] [PubMed] [Google Scholar]
  34. Rautenstrauss B., Nelis E., Grehl H., Pfeiffer R. A., Van Broeckhoven C. Identification of a de novo insertional mutation in P0 in a patient with a Déjérine-Sottas syndrome (DSS) phenotype. Hum Mol Genet. 1994 Sep;3(9):1701–1702. doi: 10.1093/hmg/3.9.1701. [DOI] [PubMed] [Google Scholar]
  35. Rozear M. P., Pericak-Vance M. A., Fischbeck K., Stajich J. M., Gaskell P. C., Jr, Krendel D. A., Graham D. G., Dawson D. V., Roses A. D. Hereditary motor and sensory neuropathy, X-linked: a half century follow-up. Neurology. 1987 Sep;37(9):1460–1465. doi: 10.1212/wnl.37.9.1460. [DOI] [PubMed] [Google Scholar]
  36. Sarkar G., Yoon H. S., Sommer S. S. Dideoxy fingerprinting (ddE): a rapid and efficient screen for the presence of mutations. Genomics. 1992 Jun;13(2):441–443. doi: 10.1016/0888-7543(92)90266-u. [DOI] [PubMed] [Google Scholar]
  37. Schäffer A. A., Gupta S. K., Shriram K., Cottingham R. W., Jr Avoiding recomputation in linkage analysis. Hum Hered. 1994 Jul-Aug;44(4):225–237. doi: 10.1159/000154222. [DOI] [PubMed] [Google Scholar]
  38. Su Y., Brooks D. G., Li L., Lepercq J., Trofatter J. A., Ravetch J. V., Lebo R. V. Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10856–10860. doi: 10.1073/pnas.90.22.10856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Thomas F. P., Lebo R. V., Rosoklija G., Ding X. S., Lovelace R. E., Latov N., Hays A. P. Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome. Acta Neuropathol. 1994;87(1):91–97. doi: 10.1007/BF00386259. [DOI] [PubMed] [Google Scholar]
  40. Thomas P. K., Calne D. B. Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity. J Neurol Neurosurg Psychiatry. 1974 Jan;37(1):68–75. doi: 10.1136/jnnp.37.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Valentijn L. J., Baas F., Wolterman R. A., Hoogendijk J. E., van den Bosch N. H., Zorn I., Gabreëls-Festen A. W., de Visser M., Bolhuis P. A. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992 Dec;2(4):288–291. doi: 10.1038/ng1292-288. [DOI] [PubMed] [Google Scholar]
  42. Villanova M., Timmerman V., De Jonghe P., Malandrini A., Rizzuto N., Van Broeckhoven C., Guazzi G., Rossi A. Charcot-Marie-Tooth disease: an intermediate form. Neuromuscul Disord. 1998 Aug;8(6):392–393. doi: 10.1016/s0960-8966(98)00044-3. [DOI] [PubMed] [Google Scholar]
  43. Warner L. E., Hilz M. J., Appel S. H., Killian J. M., Kolodry E. H., Karpati G., Carpenter S., Watters G. V., Wheeler C., Witt D. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 1996 Sep;17(3):451–460. doi: 10.1016/s0896-6273(00)80177-4. [DOI] [PubMed] [Google Scholar]
  44. Wilton S. D., Honeyman K., Fletcher S., Laing N. G. Snapback SSCP analysis: engineered conformation changes for the rapid typing of known mutations. Hum Mutat. 1998;11(3):252–258. doi: 10.1002/(SICI)1098-1004(1998)11:3<252::AID-HUMU11>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  45. de Visser M. Diagnostic criteria for autosomal dominant hereditary motor and sensory neuropathy type Ia. Neuromuscul Disord. 1993 Jan;3(1):77–79. doi: 10.1016/0960-8966(93)90045-l. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES